GENVOYA
150MG/150MG/200MG/10MG TBL FLM 90(3X30)
| SÚKL code | 0209034 |
|---|---|
| Name of the product | GENVOYA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | GENVOYA |
| Supplement | 150MG/150MG/200MG/10MG TBL FLM 90(3X30) |
| Strenght | 150MG/150MG/200MG/10MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 90(3X30) |
| Route | Oral use |
| Wrap type | Tablet container |
| Legal status | na lékařský předpis |
| Active substance |
EMTRICITABINE (EMTRICITABINUM) ELVITEGRAVIR (ELVITEGRAVIRUM) COBICISTAT (COBICISTATUM) TENOFOVIR ALAFENAMIDE FUMARATE (TENOFOVIRI ALAFENAMIDI FUMARAS) |
| ATC group | J05AR18 |
| ATC group name | EMTRICITABIN, TENOFOVIR-ALAFENAMID, ELVITEGRAVIR A KOBICISTAT |
Marketing authorisation information
| Registration Number | EU/1/15/1061/002 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Gilead Sciences Ireland UC, Carrigtohill |
| MA Holder country | IRSKO |
cz